To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.

2019 Perceptions and Insights Study: Part 1

Editor’s note: The best way to learn about people’s experience with clinical research is to ask them directly. That’s why we value the biennial Perceptions & Insights Study conducted by the Center for Information and Study on Clinical Research Participation (CISCRP). Every two years, they ask thousands of people worldwide (those who have participated in clinical trials and those who have not) about clinical research. In the first of our two-part infographic series, we focus on a subset of CISCRP’s findings on general perceptions of clinical research.

“Reality is ultimately a selective act of perception and interpretation. A shift in our perception and interpretation enables us to break old habits and awaken new possibilities for balance, healing, and transformation.” – David Simon, author and producer.

Perceptions often guide decision-making. In order to better understand health decisions – such as whether to participate in a clinical trial – we need to gather a clear picture of how people perceive clinical research as a care option.

According to CISCRP’s 2019 Perceptions & Insights Study, people are motivated to participate in research for altruistic reasons like helping advance science and helping others who may suffer from the disease. The top two barriers to participation are fear of taking a risk with their health (including side effects) and risks of clinical trials in general. Insights like these can inform how we talk about and promote clinical research to improve participation.

The CISCRP data also suggests that once someone participates in clinical research, they are either very willing or somewhat willing to participate in another research study (96% combined). For those who haven’t previously participated in a trial, they still show a high level of interest in participation (80% willing or somewhat willing).

The data highlighted in the CISCRP survey shows that people are interested in clinical research as a care option. Ultimately, if we can build upon their willingness to consider clinical research by designing the trial experience in a way that helps mitigate the barriers, we can perhaps increase the number of people who participate in research and help them navigate their health care journey in new ways.

For the full CISCRP 2019 Perceptions and Insights Study, click on this link:

CISCRP Infographic Part1

Tags: Education, Infographic,

Recent Articles

From Alzheimer’s Diagnosis to Advocate

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
January 31st, 20225 minute read

Geri had been involved in research in addition to having a healthcare background. Because of this, after being diagnosed with Alzheimer's she knew that she wanted to participate in a clinical trial.

Committed to Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 24th, 20211 minute read

Lilly has a strong legacy in cancer research. Our dedicated oncology team work together to create medicines that make life better for people around the world.

Proud Partners in Breast Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 22nd, 20213 minute read

Lilly is proud to foster true partnerships with external stakeholders. By working together to raise awareness of breast cancer research, we can make life better for people around the world.

Recommendations for Decentralized Clinical Trial Capabilities in the Wake of COVID-19

Kevin Hudziak
September 15th, 20214 minute read

Tips to implement an effective and successful decentralized clinical trial for multiple touch points.

The COVID-19 Pandemic Changed How Sites Conduct Clinical Trials Forever

Kevin Hudziak
July 29th, 20213 minute read

To better understand how various countries adapted to execute clinical trials during a pandemic, we conducted a series of virtual feedback sessions with clinicians from all over the world.

This site is intended for US residents.